Mallinckrodt has publicly disclosed its imminent initiation of the next phase of...
Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlig...
Medtronic’s pursuit of FDA approval for its blood pressure treatment device has ...
The recent approvals signal a swifter turnaround for Regeneron than what analyst...
In a significant stride toward safeguarding the health of newborns, the Food and...
The Serra Pamies facility located in Reus, Spain, has had its manufacturing oper...
Due to issues that arose with the CRO responsible for developing Pfizer’s Lyme d...
Hutchmed, a pharmaceutical company, is in the final stages of preparing a submis...
In a surprising turn of events, Gilead Sciences’ hopes for its magrolimab therap...
Novo Holdings, a prominent global life science investor renowned for fostering g...
After a string of failures in the clinic, the Tecentriq/Cabometyx combination de...
In the most recent update regarding U.K. cellular therapy firm Celixir in July 2...
After learning about a novel method for treating overactive bladder, the FDA has...
Nevro’s high-frequency neurostimulation system, after being granted FDA approval...
Midstage results indicated that Galecto’s inhalation treatment for idiopathic pu...
While dental technology has advanced significantly over the years, the ability t...
